Activating Mutations in PIK3CB Confer Resistance to PI3K Inhibition and Define a Novel Oncogenic Role for p110β
Nakanishi, Yoshito, Walter, Kimberly, Spoerke, Jill M, O'Brien, Carol, Huw, Ling Y, Hampton, Garret M, Lackner, Mark R
Published in Cancer research (Chicago, Ill.) (01.03.2016)
Published in Cancer research (Chicago, Ill.) (01.03.2016)
Get full text
Journal Article
Development of a robust RNA-based classifier to accurately determine ER, PR, and HER2 status in breast cancer clinical samples
Wilson, Timothy R., Xiao, Yuanyuan, Spoerke, Jill M., Fridlyand, Jane, Koeppen, Hartmut, Fuentes, Eloisa, Huw, Ling Y., Abbas, Ilma, Gower, Arjan, Schleifman, Erica B., Desai, Rupal, Fu, Ling, Sumiyoshi, Teiko, O’Shaughnessy, Joyce A., Hampton, Garret M., Lackner, Mark R.
Published in Breast cancer research and treatment (01.11.2014)
Published in Breast cancer research and treatment (01.11.2014)
Get full text
Journal Article
PROMISING CLINICAL DATA FROM DOSE ESCALATION IN A PHASE IB/II ONGOING STUDY OF MOSUNETUZUMAB WITH POLATUZUMAB VEDOTIN FOR RELAPSED/REFRACTORY B‐CELL NON‐HODGKIN’S LYMPHOMA
Diefenbach, C, Budde, E, Chavez, J, Lossos, I. S, Mehta, A, Dorritie, K, Kamdar, M, Negricea, R, Pham, S, Hristopoulos, M, Huw, Ling-Y, Hear, C. O, Oki, Y, To, I, Ghosh, N
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
Abstract B28: Activating mutations in PIK3CB confer resistance to PI3K inhibition in PTEN-deficient breast cancer and define a novel oncogenic role for p110β
Nakanishi, Yoshito, Walter, Kimberly M., Spoerke, Jill M., O'Brien, Carol, Huw, Ling Y., Hampton, Garret M., Lackner, Mark R.
Published in Molecular cancer research (01.02.2016)
Published in Molecular cancer research (01.02.2016)
Get full text
Journal Article